Release Date: 24/02/16 14:17 Summary: ASIC Financial Reporting Relief Application Price Sensitive: No Download Document 414.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%